65. Primary immunodeficiency Clinical trials / Disease details
Clinical trials : 500 / Drugs : 614 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 217
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03645486 (ClinicalTrials.gov) | July 1, 2018 | 24/7/2018 | Lentiviral Gene Therapy for CGD | Lentiviral Gene Therapy for Chronic Granulomatous Disease (CGD) | Chronic Granulomatous Disease | Genetic: Infusion of lentiviral TYF-CGD-modified autologous stem cells | Shenzhen Geno-Immune Medical Institute | NULL | Recruiting | N/A | N/A | All | 10 | N/A | China |